Astryx

An AI trading assistant that helps you create, test, and run your strategies.
Sign up on our website to join the waitlist 👇🏻👇🏻

[Astryx @astryx_ai]

Building India's First "AI Trading Partner" that makes you REAL MONEY 🤑

We are a group of traders who have managed a portfolio worth 5-6 Crores!

We kept seeing the same problem, again and again.

❌Trading tools were built for coders, not traders.
❌Strategies were hard to deploy, rigid by design, and completely ignored how different people think about risk. If you did not fit the system, you lost.

So we decided to solve for this.

Imagine a trading system that notices:
✅You exit winners early
✅You hold losers longer
✅You overtrade on certain days

And reminds you before you repeat it.
That’s intelligence. We’re closer to this than people think!

▶️Introducing Astryx:
An AI Trading partner that helps you make decisions that make real money.

Sign up and try for FREE now.
https://t.co/YgJBUQD0ne

[Astryx @astryx_ai]

Research, execution, strategy building, backtesting, charting with most Intelligent & latest AI models.

All in one place. No code. No switching tabs.

→ https://t.co/VGthl47uNc

#AlgoTrading #IndianStockMarket #NSE #OptionsTrading #Zerodha #Astryx #AI #ChatGPT #Anthropic

[Astryx @astryx_ai]

Most traders juggle 8+ platforms every day.

We replaced all of them.

Here's Astryx vs every tool in your current trading stack 🧵

[Astryx @astryx_ai]

The wait is over.

Waitlist users — you're in.
New users — the doors are open.

India's first AI-powered trading OS is now live.
No code. No limits.

→ https://t.co/ivdYYcVloR

#Astryx #TradingCommunity #TradingEducation #StockTrading

[Astryx @astryx_ai]

BEL – Breakout After Retest

Structure:
BEL has broken out of a symmetrical triangle after consolidating above the 20 & 50 EMA, indicating strong underlying trend support.

Price Action:
Post-breakout, the stock completed a healthy retest of the breakout zone and is now showing continuation with rising volumes, confirming buyer participation.

Options Data Insight:

₹470 is acting as the immediate resistance due to Call OI build-up.
A sustained move above ₹470 could trigger Call short covering, potentially accelerating the upside move.

Options Bias:

Bullish above ₹470. Momentum could expand quickly if OI resistance gets cleared.

[Astryx @astryx_ai]

Astryx Market Bytes - 04 Mar 2026
🔴 Gift Nifty indicates a negative start
💰 FIIs: –₹3,295 Cr | DIIs: +₹8,593 Cr

Nifty: Bearish, below 25,000
Supply: 25,000 | Support: 24,550
Sensex: Weak, near key support
Support: 79,500
Bank Nifty: Under pressure
Support: 59,800

👀 Stocks to Watch
• BEL – VCP breakout near 450
• INDIGO – Breakdown below 4,545
• OIL – Key support around 475

Checkout @astryx_ai to improve your trading experience and to build, backtest & run trading strategies effortlessly.

#StockMarket #Nifty50 #BankNifty #Trading #IndianMarkets

[Astryx @astryx_ai]

Astryx Morning Market Bytes | 02 Mar 2026

🔴 Gift Nifty signals a negative open
💰 FIIs: –₹7,536 Cr | DIIs: +₹12,293 Cr

Nifty: Bearish → Sell on rise
Res: 25,250 | Sup: 25,000–24,750

Sensex: Drifting lower
Res: 81,550–81,600 | Sup: 80,500–80,200

Bank Nifty: Under pressure
Res: 60,650 | Sup: 59,850–59,300

👀 Stocks in focus:
• Oil India – EMA-supported bullish
• Glenmark Pharma – VCP setup near highs
• Sarda Energy – IH&S breakout with volume

Checkout @astryx_ai to improve your trading experience and to build, backtest & run trading strategies effortlessly.

#StockMarket #Nifty50 #BankNifty #Trading #IndianMarkets

[Astryx @astryx_ai]

Indian Overseas Bank | Base Formation – Options View

The stock appears to be building a base around the ₹33 zone and has started inching higher, reclaiming the 20 & 50 EMA which is a sign of improving short-term momentum.

The ₹35.50 level is now a key pivot. Sustaining above this zone keeps the structure constructive and acts as immediate support.

As long as price holds above ₹35.50, a gradual move toward the ₹38 resistance zone looks possible in the near term.

Options Angle:

Traders can consider a bullish bias above ₹35.50, favoring near-term ATM/ slightly ITM Call options.
A sustained move toward ₹38 could expand premiums meaningfully due to delta acceleration.
Conservative traders may wait for strong price stability above ₹35.50 before building positions.

Price acceptance below ₹35.50 may weaken momentum and reduce bullish probability, so risk management remains key.

[Astryx @astryx_ai]

Natco Pharma Limited - Approaching a Crucial Breakout Zone

After finding support around ₹700, the stock entered a phase of sideways consolidation, forming a volatility contraction pattern — a typical sign of accumulation.

The price is now testing the 50 EMA near ₹905, which coincides with a key resistance level. This makes the ₹905 zone a critical area to watch.

Volumes are gradually picking up, indicating increasing participation as the stock nears resistance.

A strong and sustained move above ₹905 could confirm a breakout from the consolidation range and open the door for the next upward leg.

[Astryx @astryx_ai]

Your biggest edge is not speed.
It’s memory.

Humans forget patterns in their own behavior.
Machines don’t.

The moment your trading system starts remembering your mistakes,

Things change.
That’s where compounding begins.

#astryx

[Astryx @astryx_ai]

Asian Paints posted a surprise quarterly profit drop, and its shares fell after the results.

The profit was lower than market expectations, mainly due to one-time costs linked to new labour provisions, even though decorative paint sales grew.

For investors,
>this result shows how company costs and regulatory changes can impact earnings more than topline growth.

As a platform, we are watching how analysts revise earnings and price targets, because today’s earnings surprise could affect short-term stock positioning and sector sentiment.

#astryx

[Astryx @astryx_ai]

The market is finally finding some reasons to breathe after a rough patch!!!

>Talks of the U.S. cutting tariffs on Indian exports
>fresh momentum on an India-EU trade deal are giving investors something positive to latch onto.
>Add in the RBI pumping liquidity into the system and it eases some pressure on credit and sentiment.

But this isn’t a full rally yet...we’re in the “hope building” phase, and real gains will only show if these headlines turn into actual economic wins.

what do you think?

#astryx

[Astryx @astryx_ai]

IPO rush slows down in early 2026.

Here’s what’s going on.
>After a very active 2025, the primary market has slowed down sharply.
>So far in 2026, only 3 IPOs have hit the market.

The reason is simple:
market correction + weak sentiment.

What’s happening
>Mid and small-cap stocks corrected sharply.
>Several recent IPOs struggled after listing.
>Companies don’t want to risk poor pricing or a weak debut.

As a result, many IPOs are being postponed, not cancelled.

What YOU should know:

▶️This is a pause, not the end of IPOs
Over 200 companies are still in the IPO pipeline.
Around 88 companies already have SEBI approval, aiming to raise more than ₹1 lakh crore.

▶️Timing matters more than hype
In shaky markets, even good businesses can list badly.
Companies are waiting for stability instead of forcing listings.

▶️Big names are still coming
Expected IPOs include well-known companies across fintech, consumer tech, and manufacturing.
Once markets settle, activity can pick up quickly.

▶️For investors:
be patient
Fewer IPOs right now reduces noise.
When the pipeline opens again, quality and valuation will matter more than excitement.

maybe...sometimes, not listing is the smartest move.

[Astryx @astryx_ai]

Hannah Joseph Hospital SME IPO Update

• The IPO opens on January 22, 2026 and runs through January 27.
• Price band is set at ₹67 to ₹70 per share.
• The hospital is raising around ₹42 crore through this issue.
• Around ₹12 crore came from anchor investors before the public launch.
• Funds will be used to expand capacity and build a radiation oncology centre.
• The plan is to list on the BSE SME platform on January 30, 2026.
• Early anchor interest shows confidence in the healthcare play.

[Astryx @astryx_ai]

6/ Bottom line (plain and simple)

• Don’t panic buy because prices are high
• Start small and average in
• Use ETFs or bonds rather than jewellery for investing
• Think long term, not short flip

If markets stay shaky, gold can buffer losses in riskier assets.

Ask #astryx

[Astryx @astryx_ai]

Should you buy gold right now? (Updated Jan 20, 2026)

Gold and silver prices just hit record highs on Indian commodity exchanges, with

gold moving above ₹1.46 lakh per 10g and
silver pushing past ₹3.19 lakh per kg.

We’ll break down:
> Why prices are high
> What experts and brokers recommend

🧵 Whether it’s a good time to buy, and how (not just if).

[Astryx @astryx_ai]

5/ A practical rule Some wealth planners suggest keeping gold around 10-15% of a diversified portfolio.

More than that usually means you’re overweight gold relative to stocks, bonds, etc.